Accuracy of Medicare Claim–based Algorithm to Detect Breast, Prostate, or Lung Cancer Bone Metastases
Authors:
- 1 December 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Medical Care
- Vol. 55 (12) , e144-e149
Abstract
Background: We had previously developed an algorithm for Medicare claims data to detect bone metastases associated with breast, prostate, or lung cancer. This study was conducted to examine whether this algorithm accurately documents bone metastases on the basis of diagnosis codes in Medicare claims data. Methods: We obtained data from Medicare claims and electronic medical records of patients 65 years or older with a breast, prostate, or lung cancer diagnosis at a teaching hospital and/or affiliated clinics during 2005 or 2006. We calculated the sensitivity and positive predictive value (PPV) of our algorithm using medical records as the “gold standard.” The κ statistic was used to measure agreement between claims and medical record data. Results: The agreement between claims and medical record data for bone metastases among breast, prostate, and lung cancer patients was 0.93, 0.90, and 0.69, respectively. The sensitivities of our algorithm for bone metastasis in patients with breast, prostate, and lung were 96.8% [95% confidence interval (CI)=83.8% to 99.4%], 91.7% (95% CI=78.2% to 97.1%), and 74.1% (95% CI=55.3% to 86.8%), respectively; and the PPVs were 90.9% (95% CI=76.4% to 96.9%), 91.7% (95% CI=78.2% to 97.1%), and 71.4% (95% CI=52.9% to 84.8%), respectively. Conclusions: The algorithm for detecting bone metastases in claims data had high sensitivity and PPV for breast and prostate cancer patients. Sensitivity and PPV were lower but still moderate for lung cancer patients.Keywords
This publication has 22 references indexed in Scilit:
- Predicting Life Expectancy for Community-dwelling Older Adults From Medicare Claims DataAmerican Journal of Epidemiology, 2013
- Mortality following bone metastasis and skeletal-related events among patients 65 years and above with lung cancer: A population-based analysis of U.S. Medicare beneficiaries, 1999-2006Lung India, 2013
- Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999–2006Breast Cancer Research and Treatment, 2011
- Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries, 1999–2006Prostate Cancer and Prostatic Diseases, 2011
- A method to predict breast cancer stage using Medicare claimsEpidemiologic Perspectives & Innovations, 2010
- Administrative and Claims Records as Sources of Health Care Cost DataMedical Care, 2009
- Pathologic fractures correlate with reduced survival in patients with malignant bone diseaseCancer, 2007
- E06-01: Pathogenesis of lung cancer bone metastasisJournal of Thoracic Oncology, 2007
- Validation of self reported diagnosis of hypertension in a cohort of university graduates in SpainBMC Public Health, 2005
- Metastatic bone disease: clinical features, pathophysiology and treatment strategiesCancer Treatment Reviews, 2001